ID   HEI-OC1
AC   CVCL_D899
SY   HEIOC1; House Ear Institute-Organ of Corti 1
DR   BTO; BTO_0004862
DR   Wikidata; Q27653205
RX   PubMed=12811000;
RX   PubMed=26854618;
RX   PubMed=26930622;
WW   http://www.molmeth.org/protocol/culturing-hei-oc1
CC   Characteristics: Growth at the permissive (33 Celsius) temperature results in dedifferentiation of the cells and accelerated proliferation. At the restrictive temperature (39 Celsius) cell proliferation halts in about 48h.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; SV40 large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Ear, inner ear, cochlea, organ of Corti; UBERON=UBERON_0002227.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   7D
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
RX   PubMed=12811000; DOI=10.1159/000071059;
RA   Kalinec G.M., Webster P., Lim D.J., Kalinec F.;
RT   "A cochlear cell line as an in vitro system for drug ototoxicity
RT   screening.";
RL   Audiol. Neurootol. 8:177-189(2003).
//
RX   PubMed=26854618; DOI=10.1016/j.heares.2016.02.001;
RA   Park C., Thein P., Kalinec G.M., Kalinec F.;
RT   "HEI-OC1 cells as a model for investigating prestin function.";
RL   Hear. Res. 335:9-17(2016).
//
RX   PubMed=26930622; DOI=10.1016/j.heares.2016.02.019;
RA   Kalinec G.M., Thein P., Park C., Kalinec F.;
RT   "HEI-OC1 cells as a model for investigating drug cytotoxicity.";
RL   Hear. Res. 335:105-117(2016).
//